'Govt needs to phase out branded drugs to promote generic medications'

DNA: MCI cracks the whip on errant hospitals, doctors; directs them to prescribe generic drugs

MCI directs hospitals, doctors across India to prescribe generic medicines to patients

Generic drugs: Are they as effective as brand-name versions?

Modi govt aims to break doctor-pharma company nexus, medicines will become cheaper

Germany suspends marketing of 54 drugs tested by India's GVK Bio

EU suspends sale of 700 generic drugs made in India

Pharmexcil sees $1.2 billion export hit from EU ban

Lupin, Cipla bid for UCB's US generic drugs portfolio: Report

Endo to buy Par Pharmaceutical for $8.05 billion

India may take WTO action against EU over drug clinical trials: GVK

Novartis profits jump 12% on new drug sales

GVK Bio offers to re-do studies after EU ruling

France, Germany suspend some drug approvals over Indian data

US court refuses Ranbaxy appeal to block ANDA nod for 2 drugs

US denies Ranbaxy's bid to block launch of rival generics

US court overturns bid by Ranbaxy to block launch of rival generic drugs

Indian drugmakers see US sales hit by delay in new approvals

Lupin launches generic Ciprofloxacin in US market